Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Jarupa SoongsathitanonPranisa JamjuntraNuttavut SumransubSupaporn YangngamMarjorie De la FuenteGlauben LandskronPeti ThuwajitMarcela A HermosoChanitra ThuwajitPublished in: Journal of immunology research (2021)
Signals from the tumor microenvironment (TME) have a profound influence on the maintenance and progression of cancers. Chronic inflammation and the infiltration of immune cells in breast cancer (BC) have been strongly associated with early carcinogenic events and a switch to a more immunosuppressive response. Cancer-associated fibroblasts (CAFs) are the most abundant stromal component and can modulate tumor progression according to their secretomes. The immune cells including tumor-infiltrating lymphocytes (TILs) (cytotoxic T cells (CTLs), regulatory T cells (Tregs), and helper T cell (Th)), monocyte-infiltrating cells (MICs), myeloid-derived suppressor cells (MDSCs), mast cells (MCs), and natural killer cells (NKs) play an important part in the immunological balance, fluctuating TME between protumoral and antitumoral responses. In this review article, we have summarized the impact of these immunological players together with CAF secreted substances in driving BC progression. We explain the crosstalk of CAFs and tumor-infiltrating immune cells suppressing antitumor response in BC, proposing these cellular entities as predictive markers of poor prognosis. CAF-tumor-infiltrating immune cell interaction is suggested as an alternative therapeutic strategy to regulate the immunosuppressive microenvironment in BC.
Keyphrases
- poor prognosis
- regulatory t cells
- induced apoptosis
- dendritic cells
- long non coding rna
- cell cycle arrest
- natural killer cells
- oxidative stress
- stem cells
- signaling pathway
- bone marrow
- extracellular matrix
- peripheral blood
- autism spectrum disorder
- cell death
- intellectual disability
- endothelial cells
- cell proliferation
- immune response
- polycyclic aromatic hydrocarbons
- childhood cancer